Arbutus Biopharma (ABUS) EBT Margin Growth (5y) (2018 - 2026)
Arbutus Biopharma (ABUS) EBT Margin Growth (5y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Arbutus Biopharma | 922.95 Mn | 830.33 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 32,137.00 |
| Mar 31, 2026 | 86,999.00 |
| Dec 31, 2025 | 29,265.00 |
| Sep 30, 2025 | -22,980.00 |
| Jun 30, 2025 | 95,375.00 |
| Mar 31, 2025 | -46,095.00 |
| Dec 31, 2024 | 69,921.00 |
| Sep 30, 2024 | 163,587.00 |
| Jun 30, 2024 | 242,033.00 |
| Mar 31, 2024 | 225,028.00 |
| Dec 31, 2023 | 18,722.00 |
| Sep 30, 2023 | 138,031.00 |
| Jun 30, 2023 | -61,601.00 |
| Mar 31, 2023 | 99,180.00 |
| Dec 31, 2022 | 202,651.00 |
| Sep 30, 2022 | -12,683.00 |
| Jun 30, 2022 | 165,732.00 |
| Mar 31, 2022 | 755,810.00 |
| Dec 31, 2021 | 13.21 Mn |
| Sep 30, 2021 | 195,806.00 |